Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation

Journal of Neurology Neurosurgery and Psychiatry

Volumn 61, Issue 6, 1996, Pages 621-624

  Campodonico, Jeffrey R ^a   Codori, Ann Marie ^a   Brandt, Jason ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Huntington's disease; Longitudinal studies; Neuropsychological tests

Indexed keywords

REPETITIVE DNA;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; HUNTINGTON CHOREA; MALE; MENTAL CAPACITY; MENTAL DISEASE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; TRINUCLEOTIDE REPEAT;

EID: 0030465540     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.61.6.621     Document Type: Article

References (32)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
2. Gusella JF, Wexler N, Conneally P, et al. A polymorphic DNA marker linked to Huntington's disease. Nature 1983;306:234-8.
3. Strauss ME, Brandt J. Are there neuropsychological manifestations of the gene for Huntington's disease in asymptomatic, at-risk individuals? Arch Neurol 1990;47:905-8.
4. Rothlind JC, Brandt J, Zee D, Codori AM, Folstein S. Unimpaired verbal memory and oculomotor control in asymptomatic adults with the genetic marker for Huntington's disease. Arch Neurol 1993;50:799-802.
5. Blackmore L, Simpson SA, Crawford JR. Cognitive performance in a UK sample of presymptomatic people carrying the gene for Huntington's disease. J Med Genet 1995; 32:358-62.
6. Giordani B, Berent S, Boivin MJ, et al. Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Arch Neurol 1995;52:59-64.
7. Jason GW, Pajurkova EM, Suchowersky O, et al. Presymptomatic neuropsychological impairment in Huntington's disease. Arch Neurol 1988;45:769-73.
8. Diamond R, White RF, Myers RH, et al. Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol 1992;14:961-75.
9. Foroud T, Siemers E, Kleindorfer BS, et al. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Ann Neurol 1995;37:657-64.
10. Folstein SE, Jensen B, Leigh RJ, Folstein ML. The measurement of abnormal movement: methods developed for Huntington's disease. J Neurobehav Toxicol Teratol 1983; 5:605-9.
11. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiat 1978;35:837-44.
12. Brandt J, Quaid KA, Folstein SE, et al. Presymptomatic diagnosis of delayed-onset disease with linked DNA markers: the experience in Huntington's disease. J Am Med Assoc 1989;261:3108-14.
13. Brandt J, Butters N. The neuropsychology of Huntington's disease. Trends Neurosci 1986,9:118-20.
14. Wechsler D. Wechsler adult intelligence scale-raised. New York: The Psychological Corp, 1981.
15. Money J. A standardized road-map test of directional sense, manual. San Rafael, California: Academic Therapy Publication, 1976.
16. Semmes J, Weinstein S, Ghent L, Teuber HL. Correlates of impaired orientation in personal and extrapersonal space. Brain 1963;86:742-72.
17. Bylsma FW, Brandt J, Strauss ME. Personal and extrapersonal orientation in Huntington's disease patients and those at risk. Cortex 1992;28:113-22.
18. Brandt J. The Hopkins verbal learning test: development of a new memory test with six equivalent forms. Clin Neuropsychol 1991;5:125-42.
19. Brandt J, Corwin J, Krafft L. Is verbal recognition memory really different in Huntington's and Alzheimer's disease? J Clin Exp Neuropsychol 1992;14:773-84.
20. Smith A. Symbol digit modalities test manual. Los Angeles, California: Western Psychological Services, 1973.
21. Golden C. Stroop color and word test. Chicago, Ill: Stoelting, 1978.
22. Heaton RK. The Wisconsin card sorting test, manual. Odessa, FL: Psychology Assessment Resources, 1981.
23. Broadbent D, Cooper PF, FitzGerald P, Parkes KR. The cognitive failures questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982;21:1-16.
24. Beck AT, Steer RA. Beck depression inventory manual. San Antonio, TX: Psychological Corp, 1987.
25. Beck AT, Weisman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974;42:861-5.
26. Derogatis L. SCL-90-R Manual-II. Towson, MD: Clinical Psychometric Research, 1983.
27. N repeats in parent-offspring pairs with Huntington's disease. Am J Hum Genet 1995;57:593-602.
28. Brandt J. Cognitive investigations in Huntington's disease. In: Cermak L, ed. Neuropsychological explorations of memory and cognition: essays in honor of Nelson Butters. New York: Plenum Press, 1994:135-46.
29. Grafton ST, Mazziotta JC, Pahl JJ, St. et al. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease. Ann Neurol 1990;28:614-21.
30. Grafton ST, Mazziotta JC, Pahl JJ, et al. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. Arch Neurol 1992;49: 1161-7.
31. Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic atrisk persons. Neurology 1994;44:823-8.
32. Alward EH, Codor AM, Barta PE, Pearlson GD, Harris GJ, Brandt J. Basal ganglia volume and proximity to onset in presymptomatic Huntington's disease. Arch Neurol 1996 (in press).